BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18036193)

  • 1. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
    Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
    Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
    Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
    Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
    Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
    J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
    Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
    Ito M; Nagai T; Mizoguchi H; Sato K; Hayase M; Otsuka N; Fukakusa A; Kumagai N; Kim HC; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2007 Dec; 103(6):2589-96. PubMed ID: 17944865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
    Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice.
    Yan Y; Yamada K; Mizoguchi H; Noda Y; Nagai T; Nitta A; Nabeshima T
    Neuroscience; 2007 Apr; 146(1):50-9. PubMed ID: 17317018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
    Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
    Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
    Nagai T; Takuma K; Nabeshima T; Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of tissue plasminogen activator in the rewarding effect of morphine].
    Nagai T; Nabeshima T; Takuma K; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
    Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
    J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
    Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.
    Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K
    J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
    Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
    Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
    Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.